Anti-Microbial/Antifungal Crop Storage Treatments Market Size & Share 2026-2035

Anti-Microbial/Antifungal Crop Storage Treatments Market Size

The global anti-microbial/antifungal crop storage treatments market was valued at USD 2.7 billion in 2025 and is projected to reach USD 6.1 billion by 2035, advancing at a CAGR of 8.7% during 2026–2035. Treatment volumes are measured in Kilo Tons (KT), while revenue in USD billion remains the commercial measure. The market includes synthetic chemical fungicides, biological biocontrol products, and natural or botanical preparations used after harvest to protect cereals, fruits, vegetables, oilseeds, pulses, and specialty crops during storage, handling, and transport.

The need for treatment is anchored in avoidable deterioration after harvest. FAO estimates that 13.3% of food produced globally was lost between harvest and retail in 2023; the rate for fruits and vegetables was 25.4%, reflecting the greater exposure of perishable crops to decay during storage and distribution ^{[1]Food and Agriculture Organization of the United Nations, SDG Indicator 12.3.1: Global Food Losses, 2023 update, fao.org}. These losses are commercially material because decay reduces saleable yield, while fungal contamination can trigger quality downgrades or rejection in regulated export channels. Crop and livestock losses from disasters averaged USD 123 billion annually between 1991 and 2021, further illustrating the value at risk across agricultural supply chains ^{[2]Food and Agriculture Organization of the United Nations, Crop and Livestock Production Losses from Disasters 1991-2021, openknowledge.fao.org}.

Synthetic chemical treatments accounted for USD 1.798 billion, or 66.9%, of market revenue in 2025. Their position reflects established registrations, broad-spectrum performance, and economics suited to bulk grain, potato, and citrus treatment. Benzimidazoles, anilinopyrimidines, imidazoles, phenylpyrroles, triazoles, strobilurins, and phosphonate compounds remain integral to commercial programs. However, synthetic treatments are forecast to grow at 4.68% CAGR, compared with 14.00% for biological biocontrol treatments and 13.98% for natural and botanical treatments. Regulatory attrition, residue-sensitive procurement, and resistance management are shifting the mix of solutions, particularly in export-oriented fruit supply chains.

Asia Pacific generated USD 0.954 billion in 2025, representing 35.5% of global revenue, and is forecast to expand at 10.20% CAGR. North America accounted for USD 0.696 billion, or 25.9%, while Europe represented USD 0.632 billion, or 23.5%. Latin America contributed USD 0.242 billion, and Middle East & Africa generated USD 0.164 billion. The regional distribution reflects different demand mechanisms: formal grain-storage expansion supports Asia Pacific and Africa, whereas residue compliance and high-value fresh-produce logistics shape treatment intensity in Europe, North America, and export-focused Latin American markets.

The strategic fault line is therefore not between chemical and non-chemical products alone. Suppliers need portfolios that can preserve efficacy across changing residue rules, rotate modes of action where pathogen sensitivity declines, and fit the application equipment used by packinghouses and commercial warehouses. Regions adding storage capacity expand the addressable treatment base; regions tightening residue requirements determine which product platforms can command that base over time.

Key Drivers

Post-harvest loss exposure raises the economic value of treatment programs

FAO estimates that fruits and vegetables face a 25.4% food-loss rate between harvest and retail in 2023. The resulting demand is not limited to applying more fungicide. It favors systems that keep commodity quality stable across handling, storage, and transport, especially where mold can cause visible decay, mycotoxin risk, or a shipment-quality claim. In markets where warehousing and cold-chain access remain uneven, each new formal storage node can convert losses that were previously unmanaged into an addressable treatment opportunity.

Residue and phytosanitary compliance create procurement pressure

EU maximum-residue-level requirements are governed through Regulation (EC) No 396/2005 and related Commission measures, requiring exporters to align crop-protection programs with destination-market residue tolerances ^{[3]European Commission, EU Legislation on Maximum Residue Levels, food.ec.europa.eu}. COLEAD documented EU MRL changes affecting 38 plant-protection products in 2025, while Great Britain changed requirements for 42 products. For packinghouses serving more than one destination market, compliance has become a formulation and application-control issue: product choice, dose, water quality, and treatment timing must jointly protect the crop while keeping residues within the strictest applicable specification.

Commercial grain-storage investment expands formal treatment capacity

India's cooperative grain-storage program targets 700 lakh tonnes of additional capacity through an investment of approximately INR 1.25 lakh crore ^{[4]The Economic Times, PM Modi launches world's largest grain storage programme, economictimes.indiatimes.com}. The Food Corporation of India has also pursued modern wheat-silo capacity through public-private partnership development. In Africa, British International Investment's USD 26.5 million commitment to AFEX supports 20 warehouses in Nigeria, Kenya, and Uganda with 230,000 MT of capacity. Such projects do not automatically translate into treatment demand, but they create the controlled storage, loading, and operating procedures needed for recurring crop-protection programs rather than ad hoc grain handling.

Key Restraints

Active-substance withdrawals narrow the conventional treatment palette

The EU's pesticide framework continually reassesses active substances and associated MRLs. Commission Implementing Regulation (EU) 2025/787 extended approval periods for several substances, including fludioxonil, flutolanil, and pirimiphos-methyl, but extensions do not remove the underlying renewal risk. For suppliers, registration attrition can be more disruptive than a general decline in demand because a removed active may leave a specific crop-pathogen-use combination without an equivalent replacement. Export packinghouses must then reformulate programs, qualify alternatives, and retrain operators while maintaining commercial throughput.

Resistance raises the cost and complexity of disease control

Resistance in post-harvest pathogens can reduce the effective life of a registered fungicide. Research on Penicillium expansum has documented resistance to multiple post-harvest fungicides, while FRAC identifies known resistance concerns for Botrytis cinerea across several fungicide groups. Field evidence from Michigan blueberry isolates also showed increased resistance frequencies in 2020 and 2022 relative to 2019 for certain active substances. The operational implication is that treatment programs increasingly require rotation, sanitation, dose control, and complementary biological tools. Precision systems such as Citrosol's CATsystem are designed to maintain treatment-broth concentrations within defined operating ranges, limiting avoidable under-dosing and residue-management errors.

The near-term effect can favor suppliers with established synthetic registrations, because alternative programs need validation. Over the forecast period, however, the same constraints create room for biological, botanical, hybrid, and coating-based platforms that can reduce residue exposure or diversify pathogen-control mechanisms. The restraint is most severe for narrow portfolios dependent on a small number of conventional actives.

Anti-Microbial/Antifungal Crop Storage Treatments Market Segment Analysis

Treatment Type

Synthetic Chemical Treatments generated USD 1.798 billion in 2025, equivalent to 66.9% of market revenue, and are forecast to grow at 4.68% CAGR through 2035. Their advantage lies in established efficacy, broad registrations, and cost-effective use in bulk storage, potato treatment, and citrus drenching. Syngenta's Archive and Stadium products illustrate the use of combinations containing fludioxonil, azoxystrobin, and difenoconazole in potato disease-management programs ^{[5]Syngenta, Post-Harvest MRL Fungicides, syngenta-us.com}. The segment remains central to grain-storage economics, but its slower growth reflects greater regulatory and resistance exposure in high-value export crops.

Biological Biocontrol Treatments accounted for USD 0.546 billion, or 20.3%, of revenue in 2025 and are forecast to grow at 14.00% CAGR. Microbial products differentiate through competitive exclusion, nutrient competition, biofilm formation, and other non-single-site mechanisms. Lallemand Plant Care's Bio-Save 10 LP is based on Pseudomonas syringae and is used for post-harvest disease control across potatoes, pome fruits, cherries, citrus, and other crops ^{[6]Lallemand Plant Care, Bio-Save 10 LP, lallemandplantcare.com}. Certis Biologicals positions Howler EVO around multiple biological mechanisms, including antifungal metabolites, iron competition, and cell-wall-degrading enzymes. These products are most commercially attractive where residue specifications and resistance-management requirements justify a premium treatment program.

Natural and Botanical Treatments represented USD 0.344 billion, or 12.8%, of 2025 revenue, and are projected to expand at 13.98% CAGR. The category includes essential oils, plant extracts, chitosan systems, and naturally derived antifungal compounds. STK Bio-ag Technologies markets Timorex Gold as a tea-tree-oil-based biofungicide and offers hybrid products combining botanical and conventional active ingredients. AgroFresh's CeraFruta uses natamycin and is positioned for organic post-harvest applications. Their adoption is strongest where treatment programs must balance pathogen efficacy, organic compatibility, and residue-sensitive retail requirements.

Crop Type

Cereals and Grains formed the largest crop segment, generating USD 0.946 billion in 2025 and accounting for 35.2% of revenue. The segment is forecast to grow at 6.66% CAGR. Revenue per treated unit is lower than for fruits because bulk commodities operate under tighter margins, but the size of commercial grain flows and the expansion of formal storage infrastructure sustain demand. Mycotoxin prevention, grain-condition preservation, and fumigant alternatives will determine the mix of solutions used in this segment.

Fruits generated USD 0.787 billion in 2025, representing 29.3% of market revenue, and are forecast to grow at 10.27% CAGR. Citrus, pome fruits, stone fruits, and tropical fruits require higher treatment intensity because decay risk must be managed across packing, cold storage, and transport. Resistance management is especially consequential in citrus and pome-fruit systems, where Penicillium and Botrytis pressure can make treatment timing and active selection decisive for commercial shelf life.

Vegetables accounted for USD 0.411 billion, or 15.3%, of revenue in 2025 and are projected to grow at 10.17% CAGR. Potato storage remains a major application because tubers are held for extended periods and can develop storage diseases that reduce usable yield. The segment also benefits from expanding cold-chain capacity, which extends the storage window in which treatment programs can protect product quality.

Oilseeds and Pulses generated USD 0.333 billion in 2025, equal to 12.4% of market revenue, and are forecast to expand at 8.59% CAGR. Aflatoxin management is the defining commercial issue in groundnuts, maize, and other susceptible commodities. EU contaminant limits establish strict maximum levels for aflatoxins in certain food categories. Research on post-harvest storage systems found that hermetic PICS bags limited aflatoxin B1 accumulation more effectively than traditional jute-sack storage, demonstrating that treatment value is closely tied to storage-system design rather than product selection alone.

Spices, Herbs, and Specialty Crops accounted for USD 0.210 billion, or 7.8%, of 2025 revenue, and are projected to grow at 7.82% CAGR. The segment combines high underlying commodity values with fragmented supply chains and demanding contaminant or residue requirements. Botanical treatments have a particular fit where essential-oil-based products align with clean-label positioning, although fragmented warehousing and smaller lot sizes can limit formal program adoption. Research on stored wheat found that selected essential-oil treatments could inhibit Aspergillus flavus growth under controlled conditions, supporting continued development of botanical antifungal systems.

Formulation

Liquid Formulations represented USD 1.309 billion in 2025, or 48.7% of revenue, and are forecast to grow at 10.18% CAGR. Liquids are adaptable to drenchers, sprays, foams, dips, brushes, and microbial suspensions, making them integral to high-throughput packinghouse operations. Their commercial strength is tied to application precision: operators can adjust concentration and coverage to manage both efficacy and residues.

Solid Formulations generated USD 0.556 billion in 2025, representing 20.7% of revenue, and are forecast to grow at 6.52% CAGR. Wettable powders, granules, and dry admixtures remain relevant to grain storage because they suit loading and bulk-handling practices. Their lower forecast growth reflects the maturity of established grain-treatment markets and the slower migration of biological products into dry bulk-storage formats.

Gaseous & Fumigant Formulations accounted for USD 0.478 billion in 2025, or 17.8% of revenue, and are projected to grow at 4.72% CAGR. The phase-out of non-quarantine and pre-shipment methyl bromide use has reshaped fumigant portfolios globally. Phosphine remains important, yet resistance among stored-grain insect pests is a growing operational concern, increasing the value of monitoring, resistance management, and alternative fumigation methods. This category remains essential for certain grain-storage situations, but its growth is constrained by regulatory change and fewer broad-spectrum replacement options.

Coatings & Film Formulations generated USD 0.344 billion in 2025, representing 12.8% of revenue, and are forecast to grow at 10.35% CAGR. Edible coatings can combine moisture-barrier, gas-exchange, and antimicrobial functions, allowing suppliers to position the formulation as both a quality-preservation system and an active-delivery platform. Their adoption is concentrated in citrus, pome fruits, and tropical fruits, where appearance, dehydration, and decay directly affect saleable value.

Coatings and biological products are not interchangeable substitutes for conventional fungicides in every use case. Their commercial advantage is strongest where operators have controlled application equipment, defined quality specifications, and the ability to capture value from better shelf life or reduced residue exposure. Suppliers that can pair conventional treatments with these newer platforms are better positioned to manage both the volume economics of grain and the quality economics of perishables.

Anti-Microbial/Antifungal Crop Storage Treatments Market Regional Analysis

North America

North America generated USD 0.696 billion in 2025, representing 25.9% of global revenue, and is forecast to grow at 7.78% CAGR. The United States combines mature fresh-produce packing systems with established conventional registrations and a growing biological product base. Bio-Save 10 LP, for example, is registered in the United States for post-harvest disease control on several high-value crops. Canada adds demand through potatoes, apples, cherries, and grain, while closely connected regulatory and commercial practices support cross-border product deployment. Growth is less about new storage capacity than about improving residue management, disease control, and the cost efficiency of high-value produce programs.

Europe

Europe accounted for USD 0.632 billion in 2025, or 23.5% of global revenue, and is forecast to expand at 6.99% CAGR. The region's lower growth rate reflects regulatory pressure on conventional actives rather than weak post-harvest demand. Spain, Italy, France, Germany, and the United Kingdom remain important fresh-produce markets because their packinghouses serve residue-sensitive retail and export channels. Frequent EU and Great Britain MRL revisions require treatment programs to be revalidated as active-substance approvals change, ^{[7]COLEAD, Yearly Review of EU and GB MRL Changes in 2025, colead.link}. Europe therefore acts as a technology-forcing market: it accelerates qualification of biological, botanical, and precision-application solutions that may later be deployed in exporter markets supplying European buyers.

Asia Pacific

Asia Pacific was the largest regional market, generating USD 0.954 billion in 2025 and accounting for 35.5% of global revenue. It is also the fastest-growing region, at 10.20% CAGR. China's grain-storage scale and fruit-export activity support demand for conventional and increasingly compliance-oriented treatments. India's storage investment program is particularly influential because new cooperative warehouses and silo assets can increase the share of grain passing through controlled storage and standardized protection practices. Japan, Australia, South Korea, and ASEAN markets add a different demand profile, shaped by residue-sensitive imports and tropical-fruit export chains. The regional opportunity is broad, but product selection will differ sharply between cost-sensitive bulk grain systems and high-value fruit packinghouses.

Latin America

Latin America generated USD 0.242 billion in 2025, representing 9.0% of revenue, and is forecast to grow at 9.11% CAGR. Brazil, Mexico, Argentina, and Chile combine export-oriented fruit production with major grain and oilseed flows. Their treatment programs must often meet EU, U.S., and Asian destination requirements, which favors suppliers that can support residue-compliant formulations and application protocols. Chilean and Brazilian fresh-fruit supply chains are particularly relevant to biological and coating adoption because the commercial value of export fruit can support higher treatment intensity.

Middle East & Africa

Middle East & Africa accounted for USD 0.164 billion in 2025, or 6.1% of market revenue, and is forecast to expand at 8.70% CAGR. South Africa is a high-intensity market due to citrus, pome-fruit, table-grape, and stone-fruit exports. Citrosol maintains a presence in South Africa, underscoring the relevance of specialist post-harvest technology in export packing operations. Elsewhere, the opportunity depends more heavily on commercial warehousing, grain preservation, and aflatoxin control. AFEX's warehouse expansion in Nigeria, Kenya, and Uganda illustrates how investment in storage infrastructure can create a platform for more systematic protection of stored commodities ^{[8]British International Investment, British International Investment commits USD 26.5 million to AFEX, bii.co.uk}.

Europe's slower growth has a wider competitive effect than its revenue share suggests. Its residue rules influence how exporters in Latin America, Africa, and Asia design treatment programs, making European regulatory developments an early signal of future portfolio requirements. Latin America and South Africa are positioned between these two forces: their export orientation makes compliance essential, while their production scale supports investment in precision application and alternative treatment platforms.

Anti-Microbial/Antifungal Crop Storage Treatments Market Share & Competitive Landscape

The market is moderately concentrated. UPL Limited held 16.2% of 2025 revenue, followed by AgroFresh Solutions Inc. at 12.6%, Syngenta AG at 9.8%, FMC Corporation at 7.1%, and Citrosol S.A. at 5.6%. Together, these five companies represented approximately 51.3% of market revenue. Competition is defined by registration reach, crop-specific application expertise, biological capabilities, formulation breadth, and the ability to support residue-sensitive supply chains.

UPL Limited held the leading market share at 16.2%. Its broad crop-protection footprint and international distribution reach support conventional fungicide, fumigation, and storage-treatment activity across established and emerging markets. UPL reported FY2025 revenue of INR 34,381 crore, with fungicides representing 25% of crop-protection revenue and BioSolutions accounting for 11% of revenue, indicating a portfolio increasingly able to address both conventional and alternative treatment demand ^{[9]UPL Limited, FY25 Business Standard filing, bsmedia.business-standard.com}.

AgroFresh Solutions Inc. held 12.6% market share and is focused on fresh-produce post-harvest systems spanning ethylene management, fungicides, coatings, sanitizers, and quality monitoring. Its March 2024 acquisition of Pace International expanded its portfolio in edible coatings, conventional fungicides, sustainable storage treatments, and application equipment. AgroFresh also entered a May 2025 collaboration with Biotalys to develop and commercialize protein-based biological fungicides for post-harvest use.

Syngenta AG held 9.8% market share. Its position is supported by a broad crop-protection registration infrastructure and post-harvest fungicide offerings, including Archive and Stadium for potato treatment applications. Its ability to combine established active ingredients in multi-mode-of-action products is important where resistance management and treatment reliability are central to packinghouse or storage economics.

FMC Corporation held 7.1% market share and participates through conventional fungicides and biological solutions. FMC's Avodigen product is based on proprietary Bacillus strains and is positioned as a biofungicide and bionematicide. The company's 2024 annual report identifies biologicals and Plant Health as part of its portfolio development, alongside its conventional crop-protection business.

Citrosol S.A. held 5.6% market share and is a specialist in citrus, pome-fruit, and tropical-fruit post-harvest treatment. Its CATsystem provides real-time dosing control for treatment solutions, aligning its equipment and chemistry offer with residue and efficacy management. Citrosol acquired Fomesa Fruitech and Brogdex Ibérica through FLC Technologies, expanding its access to pip-fruit, tuber, and international post-harvest markets.

Fomesa Fruitech S.L.U. remains within the company scope as a Valencia-based post-harvest specialist operating under Citrosol's corporate ownership following the 2024 acquisition. Its FRUITGARD-IS 7.5 imazalil formulation is designed for citrus packinghouse applications through drenching or spray treatment. Its integration illustrates the ongoing consolidation of specialist Mediterranean post-harvest suppliers.

Lallemand Plant Care is a biological crop-protection supplier with Bio-Save 10 LP as a principal post-harvest offering. The Pseudomonas syringae -based product is used for disease management across potatoes, sweet potatoes, pome fruits, cherries, and citrus. Lallemand's LALFRESH S received the SIVAL d'Argent award in 2026 for its post-harvest biocontrol positioning against Monilia on stone fruit.

Nufarm Limited participates primarily through phosphonate and conventional fungicide products. Phostrol is a phosphorous-acid fungicide, while the company also markets thiophanate-methyl products with relevance to fruit and vegetable disease-management programs. Its geographic coverage provides access to markets where conventional chemistries remain commercially important.

STK Bio-ag Technologies is a botanical biofungicide specialist. Timorex Gold and hybrid botanical-conventional products such as Yarden SE position the company in treatment programs seeking to reduce conventional chemical load while retaining reliable disease control. This hybrid approach is relevant where packinghouses are transitioning incrementally rather than replacing chemical treatment systems outright.

Xeda International S.A. is a French specialist in post-harvest fungicide formulations for citrus, pome fruit, stone fruit, and other perishables. Its Xedathane line uses pyrimethanil-based technology as part of resistance-management programs for citrus packinghouses. The company's relevance is strongest in export-oriented facilities that require crop-specific technical service alongside product supply.

Certis Biologicals focuses on multi-mechanism biological crop-protection products. Howler EVO is positioned around antifungal compounds, iron competition, enzymatic cell-wall disruption, and induced plant responses. Its portfolio supports biological integration where resistance concerns and residue-sensitive procurement make standalone conventional programs less attractive.

Recent Industry Developments

AgroFresh Solutions Inc. acquired Pace International LLC in March 2024. The transaction added Pace's edible coatings, fungicides, cleaners, sanitizers, sustainable storage treatments, and application equipment to AgroFresh's post-harvest portfolio.

AgroFresh and Biotalys announced a collaboration in May 2025. The companies agreed to develop and commercialize protein-based biological fungicides for post-harvest fresh-produce protection, extending AgroFresh's exposure to a new biological technology platform.

Citrosol expanded through the acquisition of Fomesa Fruitech and Brogdex Ibérica. The acquisition, conducted through FLC Technologies, broadened Citrosol's crop coverage and market reach in the post-harvest sector.

Lallemand Plant Care's LALFRESH S received a SIVAL d'Argent award in 2026. The product was recognized for its biocontrol positioning against Monilia on stone fruit, adding a specialized biological option to post-harvest disease-management programs.

FMC India introduced VELZO and COSUIT in 2024. VELZO combines valifenalate and mancozeb, while COSUIT is based on copper hydroxide; both launches targeted disease-management applications in Indian horticulture.

European regulatory activity continued to alter treatment-program requirements. Commission Implementing Regulation (EU) 2025/787 extended approval periods for 23 active substances, while Commission Regulation (EU) 2024/2619 amended MRL provisions for multiple active substances.